National Drug and Alcohol Research Centre. (2024) The Ecstasy and Related Drugs Reporting System (EDRS).
External website: https://ndarc.med.unsw.edu.au/project/ecstasy-and-...
The Ecstasy and Related Drugs Reporting System (EDRS) is a national monitoring system for ecstasy and related drugs that is intended to identify emerging trends of local and national interest in the markets for these drugs. The EDRS is based on the Illicit Drug Reporting System (IDRS) methodology and consists of interviews with people who regularly use ecstasy and other stimulant, as well as analysis and examination of indicator data sources related to ecstasy and other related drugs. EDRS is designed to be sensitive to trends, providing data in a timely manner, rather than describing issues in extensive detail.
You can access EDRS Reports via the following links:
B Substances > Cannabis / Marijuana
B Substances > Tobacco (cigarette smoking) > Nicotine product (e-cigarette / vaping / heated)
B Substances > Hallucinogens / Psychedelics > LSD (Lysergic acid diethylamide)
B Substances > Inhalants and solvents > Nitrous oxide (laughing gas)
B Substances > CNS stimulants
B Substances > CNS stimulants > Amphetamines
B Substances > CNS stimulants > Methamphetamine
B Substances > CNS stimulants > MDMA / Ecstasy
B Substances > Cocaine
B Substances > New (novel) psychoactive substances > Aminoindanes / Arylalkylamines / Arylcyclohexylamines > Ketamine
B Substances > New (novel) psychoactive substances > Other novel substances > GHB / GBL (Gamma hydroxybutyric / Gamma butyrolactone)
F Concepts in psychology > Behaviour > Risk-taking behaviour
J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment > Early warning monitoring system
J Health care, prevention, harm reduction and treatment > Identification and screening > Identification and screening for substance use
VA Geographic area > Australia and Oceania > Australia
Repository Staff Only: item control page